In conclusion, our results suggest that miRNA-152-3p functions as a novel regulator to promote glioma cells invasion via DNMT1-mediated downregulation of NF2 and can potentially be used as a treatment for GBM. This evidence concerns the gene NF2 and glioblastoma.